Javitt Jonathan C (CIK 0001303782)

Latest company ownership

Shares held
14,321,997
Last filed at
Aug 24, 2023
Confidence Score
50.1
2025Q4
Confidence Score History
2022Q2 2025Q4
Shares held
460,000
Last filed at
Feb 16, 2010
Confidence Score
50.0
2025Q4
Confidence Score History
2008Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 17, 2024 Dec 18, 2024 NRX Pharmaceuticals, Inc. Chair Buy 83.8 +40,000 2.71% ✗ $46.8K
Aug 23, 2023 Aug 24, 2023 NRX Pharmaceuticals, Inc. Chief Scientist Buy 68.8 +100,000 0.68% ✗ $33K
Aug 22, 2023 Aug 23, 2023 NRX Pharmaceuticals, Inc. Chief Scientist Buy 82.5 +200,000 1.38% ✗ $64.4K
Dec 7, 2022 Dec 9, 2022 NRX Pharmaceuticals, Inc. Director Sell 20.0 -400,000 -2.97% ✗ $400K
Jun 1, 2022 Jun 2, 2022 NRX Pharmaceuticals, Inc. Chief Scientist Buy 72.5 +100,000 0.68% ✗ $58K
Jun 1, 2022 Jun 2, 2022 NRX Pharmaceuticals, Inc. Chief Scientist Buy 78.8 +100,000 0.68% ✗ $5.8M
Aug 3, 2008 Feb 16, 2010 BRAINSTORM CELL THERAPEUTICS INC. Director Buy 100.0 +460,000 100.00% ✗ $264B
Aug 27, 2008 Aug 28, 2008 BRAINSTORM CELL THERAPEUTICS INC. Director Sell 26.3 -40,000 -4.00% ✗ $10K